Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Hypocalcemia Introduction Pathophysiology Etiology Diagnostic approach Management principles Introduction Calcium is the most abundant mineral in the body. In pediatric ICU, hypocalcemia has higher mortality then normocalcemia. We are interested in ionized calcium levels Calcium homeostasis Regulation of parathyroid function by calcimimetic compounds E. Nemeth, http://www.ndt-educational.org/nemethslide.asp Introduction to Anatomy and Physiology, http://ncwcbio101.wordpress.com/2008/11/23/14-introduction-toanatomy-and-physiology/ Pathophysiology Ionized calcium is affected by: Albumin Blood pH Serum phosphate Serum magnesium Serum bicarbonate Exogenous factors Citrate / free fatty acids (TPN) Why do we need it? Calcium messenger system – regulates cell function Activates cellular enzyme cascades Smooth muscle and myocardial contraction Nerve impulse conduction Secretory activity of exocrine glands Symptoms and signs of hypocalcemia Neuromuscular irritability Paresthesias Laryngospasm / Bronchospasm Tetany Seizures Chvostek sign Trousseau sign Prolonged QTc time on ECG Tetany is not caused by increased excitability of the muscles. Muscle excitability is depressed hypocalcemia impedes ACh release at NM junctions However, the increase in neuronal excitability overrides the inhibition of muscle contraction. Signs & Symptoms: A 2-in-1 Reference for Nurses, Copyright © 2007 Lippincott Williams & Wilkins, www.wrongdiagnosis.com/bookimages/14/4721.1.png Trousseau sign: (very uncomfortable and painful) A blood pressure cuff is inflated to a pressure above the patients systolic level. Pressure is continued for several minutes. Carpopedal spasm: * flexion at the wrist * flexion at the MP joints * extension of the IP joints * adduction thumbs/fingers Long QT interval with normal T waves Prolongation of the ST segment with little shift from the baseline History that suggests hypocalcemia Newborns (can be unspecific) Asymptomatic Lethargy Poor feeding Vomiting Abdominal distention Children Seizures Twitching Cramping Laryngospasm Etiology Neonatal hypocalcemia: Early neonatal hypocalcemia (48-72 hours) Prematurity Poor intake, hypoalbuminemia, reduced responsiveness to vitamin D Birth asphyxia Delay feeding, increased calcitonin, endogenous phosphate load high, alkali therapy Infant to diabetic mother Magnesium depletion → functional hypoparathyroidism → hypocalcemia IUGR Etiology Late neonatal hypocalcemia Exogenous phosphate load Phosphate-rich formulas / cow’s milk Magnesium deficiency Transient hypoparathyroidism of newborn Hypoparathyroidism Gentamycin (24 hourly dosing schedule) Etiology Infants and children Hypoparathyroidism Impaired synthesis / secretion Loss/ lack of PTH tissue or defective synthesis Primary or acquired conditions Defective calcium sensing receptor End –organ resistance to PTH (pseudohypoparathyroidism) Hypovitaminosis D (MUCH MORE COMMON) Hypomagnesemia Other Synthesis / secretion of PTH Genetic Autosomal dominant Autosomal recessive X-Linked HDR (hypoparathyroidism associated with sensorineural deafness and renal dysplasia) DiGeorge's syndrome Mitochondrial disorders: MELAS (mitochondrial encephalopathy, lactic acidosis and stroke-like episode), Synthesis / secretion Autoimmune APECED (autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy syndrome) Hypoparathyroidism Primary adrenal insufficiency Chronic mucocutaneous candidiasis Synthesis / secretion Acquired Thyroid surgery Parathyroidectomy Iron deposition with chronic transfusions Wilson’s disease Gram negative sepsis, toxic shock, AIDS ? Macrophage-generated cytokines Pseudohypoparathyroidism Target organ insensitivity to PTH (bone / kidney) Hypocalcemia Hyperphosphatemia Elevated PTH Pseudohypoparathyroidism (PHP) GNAS1 gene mutations – intracellular signals Expression in tissues either paternally / maternally determined Example: renal expression is maternal Type 1a PHP AD (maternal transmission) Albright’s hereditary osteodystrophy Albright’s Short stature & limbs Obesity Round, flat face Short 4e/5e metacarpals Archibald sign Brachydactyly Potter's thumb Eye problems IQ problems Basal ganglia calcifications Pseudopseudohypoparathyroidism Phenotype of Albright’s NORMAL serum calcium NO PTH resistance Paternal GNAS1 gene mutation Pseudohypoparathyroidism Type 1b Type 1c Hypocalcemia, no phenotypic abnormality AD, maternal transmission Looks like type 1a Type 2 No features of Albright’s PHP Ia PHP Ib PHP II PPHP Albright’s phenotype + - - + Serum calcium NL Response to PTH cAMP NL Response to Phosphorus ()NL NL Hormone Resistance All hormones PTH target tissues only PTH target tissues only None Molecular defect Gsa ?PTH R Unknown Gsa Hypovitaminosis D Decrease intake or production Increased catabolism Decrease 25-hydroxylation by liver Decrease 1-hydroxylation by kidney Delayed closure of fontanels Bossing Craniotabes Delayed eruption of teeth Rickety rosary Pectus carinatum Harrison sulcii Splaying of distal ends of long bones bones Hypotonia Weakness Growth retarded Recurrent chest infections Hypomagnesemia Magnesium is required for PTH release May also be required for effects on target organs Mechanisms: End-organ unresponsiveness to PTH Impaired release of PTH Impaired formation of 1,25-vitamin D3 Hypomagnesemia Primary Autosomal recessive Present at 1 month age with seizures Secondary Intestinal absorption vs renal excretion Other Pancreatitis Citrated products Hungry bone syndrome Hyperphosphatemia Fluoride poisoning Other Hungry bone syndrome After prolonged period of calcium absorption Rebound phase Avid uptake of calcium by bone Parallel uptake of magnesium by bone Following parathyroidectomy Workup - blood Total and ionized calcium Magnesium Phosphate UKE and s-glucose PTH Vitamin D metabolite Urine-CMP and –creatinine S-ALP Workup - imaging CXR Ankle and wrist XR Workup - other ECG Malabsorption workup Karyotyping and family screening Management 1. 2. 3. 4. Dependent on the underlying cause and severity Administration of calcium alone is only transiently effective Mild asymptomatic cases: Often adequate to increase dietary calcium by 1000 mg/day Symptomatic: Treat immediately Treatment of hypocalcaemia Symptomatic hypocalcaemia IV Calcium should only be given with close monitoring Should be on cardiac monitor Mix with NaCl or 5 % D/W (not bicarbonate/lactate containing solutions) Risks Tissue necrosis/calcification if extravasates Calcium can inhibit sinus node bradycardia + arrest Stop infusion if bradycardia develops Avoid complete correction of hypocalcaemia With acidosis and S-Ca – give Ca before correcting acidosis If Mg is cause of S-Ca – treat and correct hypomagnesaemia Treatment of hypocalcaemia Symptomatic hypocalcaemia Early neonatal hypocalcaemia Neonates: Ca gluconate:10 mg/kg (1 ml/kg of 10% solution) Slowly IV + monitoring ECG Occasionally associated transient hypomagnesaemia Treat prior to Ca administration Start oral Calcium as soon as possible Early neonatal hypocalcaemia normalizes in 2-3 days Oral Ca usually necessary for 1 week Treatment of hypocalcaemia Symptomatic hypocalcaemia Late neonatal hypocalcaemia Associated with S-phosphate Decrease phosphate intake Give calcium containing phosphate binder Oral calcium (gluconate) supplementation 100 mg/kg/dose 4 hourly per os Hypocalcaemia in older children Same dose IV as for neonates More often require continuous infusion Oral supplementation 50 mg/kg/24 hr elemental Ca Ca binds with phosphate in gut Ca absorption Advantage in conditions with s-phosphate Renal failure Hypoparathyroidism Tumor lysis Most need Vit D supplementation